MyAverix Finance
SHG · Healthcare
Pulike Biological Engineering (603566)
Biotechnology
Pulike Biological Engineering (603566) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $4.33B, P/E ratio is 29.79, net margin is 13.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603566
Pulike Biological Engineering (603566) — FAQ
What is Pulike Biological Engineering's market cap?
Pulike Biological Engineering (603566) has a reported market cap of $4.33B (data as of 2026-03-29).
What is 603566's P/E ratio?
The price-to-earnings (P/E) ratio for Pulike Biological Engineering (603566) is 29.79 (data as of 2026-03-29).
Does Pulike Biological Engineering pay a dividend?
Dividend yield is not available in the current snapshot for Pulike Biological Engineering (603566). Check the MyAverix Finance app for the latest dividend data.
What sector is Pulike Biological Engineering in?
Pulike Biological Engineering (603566) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 603566 listed on?
603566 is listed on SHG.
What is Pulike Biological Engineering's net margin?
Pulike Biological Engineering (603566) reports a net margin of 13.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.